WASHINGTON, DC (STL.News) The US Department of State released the following statement:
The text of the following statement was released by the Governments of the United States of America and India on the occasion of the third U.S.-India 2+2 Ministerial Dialogue.
India’s Minister of Defence Rajnath Singh and Minister of External Affairs Dr. S. Jaishankar welcomed U.S. Secretary of State Michael R. Pompeo and Secretary of Defense Dr. Mark T. Esper to New Delhi for the third annual U.S.-India 2+2 Ministerial Dialogue. The Ministers welcomed the elevation of the U.S.-India relationship to a Comprehensive Global Strategic Partnership during the visit of President Donald J. Trump to India in February 2020. They reiterated their commitment to further strengthening the U.S.-India partnership, anchored in mutual trust and friendship, shared commitment to democracy, converging strategic interests, and robust engagement of their citizens.
While celebrating more than seven decades of diplomatic engagement between the United States and India, the Ministers intend to expand cooperation under the 2+2 framework to realize the full potential of the U.S.-India Comprehensive Global Strategic Partnership.
Cooperation during the COVID-19 Pandemic
The Ministers applauded the exemplary cooperation between the United States and India in confronting challenges emerging from the COVID-19 pandemic. They reiterated their resolve to strengthen cooperation in the development of vaccines, therapeutics, diagnostics, ventilators and other essential medical equipment. Recognizing that bilateral engagement in research and development and the mass production of vaccines and therapeutics plays to our respective strengths, the Ministers sought to jointly promote access to high quality, safe, effective and affordable COVID-19 vaccines and treatments on a global scale. India expressed appreciation for the 200 ventilators provided by the United States Agency for International Development (USAID) to the Indian Red Cross Society, while the U.S. expressed appreciation for India’s export of Personal Protective Equipment (PPE), essential medicines, and therapeutics to the United States during these challenging times. The Ministers looked forward to the conclusion of an overarching MoU between the U.S. Department of Health and Human Services (HHS) and India’s Ministry of Health and Family Welfare, including their component agencies and departments, to enhance health cooperation, including on health emergencies and pandemics, prevention, diagnosis and treatment of communicable and non-communicable diseases, and biomedical research and innovation. The Ministers also looked forward to the signing of the Memorandum of Understanding between the U.S. National Institute of Allergy and Infectious Diseases (NIAD/NIH) and the Indian Council of Medical Research (ICMR) to collaborate through an International Center of Excellence in Research focused on infectious diseases including COVID-19 and other emerging threats. They welcomed the upcoming call for applications for clinical research fellowships for early and mid-career American and Indian scientists to help expand the cohort of physician scientists focused on research that will advance clinical practice and benefit public health in both countries. Noting the importance of health sector cooperation, they also looked forward to convening the U.S.-India Health Dialogue at an early date.
The Ministers reaffirmed efforts to enhance supply chain resilience and to seek alternatives to the current paradigm, which had come under severe strain during the pandemic and exposed critical vulnerabilities. The Ministers sought to support the global economic recovery, including in India and the United States, to emerge from the pandemic more resilient than ever.
The Ministers expressed appreciation for the repatriation of stranded U.S. and Indian nationals from both countries during the pandemic.
NOTE: this is NOT the complete release.